Jul 31, 2026 09:00AM
Jul 30, 2026 06:51AM
Jul 28, 2026 08:22AM
Jul 28, 2026 07:10AM
Jul 20, 2026 05:14AM
Jul 13, 2026 09:20AM
Jul 13, 2026 07:01AM Alkermes drug shows sustained narcolepsy benefits at nine months
Jul 13, 2026 03:13AM
Jul 8, 2026 08:10AM
Jul 2, 2026 05:04AM
Jun 29, 2026 06:15AM
Jun 18, 2026 07:06AM
Jun 18, 2026 06:43AM
Jun 15, 2026 07:02AM Alkermes receives orphan drug status for alixorexton in U.S. and Europe
Jun 9, 2026 08:36AM
May 12, 2026 09:30AM
May 5, 2026 12:28PM
May 5, 2026 07:13AM
Apr 14, 2026 07:00AM
Apr 10, 2026 06:52AM
Mar 24, 2026 08:52AM Alkermes (ALKS) PT Lowered to $43 at Piper Sandler
Mar 10, 2026 08:24AM
Feb 26, 2026 06:39AM
Feb 25, 2026 07:19AM
Jan 28, 2026 02:16AM
Jan 6, 2026 07:04AM
Nov 20, 2025 06:40AM
Nov 17, 2025 05:52AM Avadel board deems Lundbeck's $2.4 billion bid superior to Alkermes deal
Nov 17, 2025 04:19AM
Nov 14, 2025 07:45AM
Nov 14, 2025 05:45AM
Nov 13, 2025 04:37AM
Nov 12, 2025 01:05PM
Nov 12, 2025 12:37PM
Nov 12, 2025 10:52AM Stifel on Alkermes (ALKS): 'this still looks like a viable commercial product in NT2'
Nov 12, 2025 09:57AM
Nov 11, 2025 06:05AM
Nov 5, 2025 12:22PM
Nov 5, 2025 08:03AM
Nov 5, 2025 07:55AM
Oct 28, 2025 03:19PM
Oct 28, 2025 01:16PM Jefferies on Alkermes (ALKS) Earnings: 'Solid Q3 + FY guide raise'
Oct 28, 2025 07:02AM
Oct 27, 2025 06:43AM
Oct 23, 2025 06:42AM
Oct 22, 2025 03:19PM
Oct 22, 2025 02:44PM
Oct 20, 2025 09:43AM
Oct 8, 2025 06:41AM Mizuho Reiterates Outperform Rating on Alkermes (ALKS)
Oct 6, 2025 08:06AM

433,570 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All